+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Hepatitis Test Solution/Diagnosis Market - Global Forecast 2026-2032- Product Image
Hepatitis Test Solution/Diagnosis Market - Global Forecast 2026-2032- Product Image
New

Hepatitis Test Solution/Diagnosis Market - Global Forecast 2026-2032

  • PDF Icon

    Report

  • 195 Pages
  • January 2026
  • Region: Global
  • 360iResearch™
  • ID: 4904514
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The hepatitis test solution/diagnosis market is rapidly evolving, presenting senior decision-makers with new challenges and opportunities as they balance technology integration, operational demands, and shifting supplier dynamics.

Market Snapshot: Hepatitis Test Solution/Diagnosis Market Size and Growth

The hepatitis test solution/diagnosis market demonstrated substantial expansion, rising from USD 3.92 billion in 2025 to USD 4.14 billion in 2026. Growth is expected to reach USD 5.79 billion by 2032, supported by a compound annual growth rate (CAGR) of 5.72%. This surge is attributed to increasing investment in healthcare diagnostics, enhanced detection of asymptomatic hepatitis cases, and the implementation of advanced technologies such as molecular diagnostics, immunoassay systems, and chromatography platforms. Accelerating innovation is notably shifting how procurement and operational leaders prioritize strategic initiatives across geographic regions and provider settings.

Scope & Segmentation of the Hepatitis Test Solution/Diagnosis Market

  • Technology Types: Platforms include chromatography—featuring FIA and HPLC; immunoassays, such as chemiluminescent immunoassays, ELISA, and rapid immunoassays; molecular diagnostics encompassing isothermal amplification, PCR, and real-time PCR.
  • Product Categories: Instruments ranging from benchtop to high-throughput models; kits and reagents segmented for chromatography, immunoassay, or molecular assay uses; software and support services for streamlined workflows.
  • End Users: Blood banks, clinics, hospital-based and independent diagnostic laboratories, general hospitals, specialty hospitals, and home care environments each present unique operational needs and priorities.
  • Test Types: Screening tests for early hepatitis detection and confirmatory assays (including ELISA-confirmatory and PCR-confirmatory tests) are integral to robust diagnostic pathways.
  • Applications: Solutions serve both clinical diagnostics and research, requiring different compliance and operational practices.
  • Geographic Regions: The Americas, Europe, Middle East & Africa, and Asia-Pacific exhibit diverse procurement behaviors, regulatory environments, and healthcare infrastructure influencing adoption timelines and strategies.

Key Takeaways for Senior Decision-Makers

  • Advanced molecular and immunoassay platforms are transforming diagnostic processes, enabling more reliable early identification of hepatitis infections.
  • Adaptability of testing platforms, alongside assured supply and analytical accuracy, is now central to procurement and long-term strategic investments.
  • Modular solutions providing integrated services enhance flexibility between centralized and point-of-care testing models.
  • Shifts in regulatory policies and clinical guidelines require leaders to regularly review and update operational protocols with suppliers and partners.
  • Manufacturers prioritizing digital innovation and integrated supply chains are better positioned to deliver stability and actionable real-time data in diagnostics.
  • Regional differences in regulations and infrastructure have a significant impact on market entry, product rollouts, and tailored go-to-market approaches.

Tariff Impact: Operational and Procurement Shifts in 2025

Tariff changes enacted in 2025 have increased both operational complexity and sourcing costs within the global supply network for hepatitis test solutions. Procurement leaders are adjusting supplier strategies, employing alternative sourcing approaches, and revising inventory planning methods to address fluctuating import costs and potential disruptions. Organizations with established local manufacturing, responsive distribution, and certified logistics are now better equipped to maintain continuity. Consequently, regulatory compliance, adherence to local content standards, and robust contingency planning are now fundamental components of procurement and budgeting decisions.

Methodology & Data Sources

This analysis utilizes a mixed-methods approach, including direct interviews with laboratory, procurement, and operations executives, complemented by discussions with manufacturing and logistics leaders. Information is validated through comprehensive literature review, peer-reviewed data, and targeted regulatory analysis to ensure practical relevance and reliability.

The Hepatitis Test Solution/Diagnosis Market: Why This Report Matters

  • Delivers a structured, actionable framework to help leaders optimize technology selection, enhance supply chain security, and guide future-focused investment decisions.
  • Connects detailed segmentation with tactical guidance for procurement, clinical effectiveness, and commercial success in hepatitis diagnostics.
  • Supports policy and operational leaders in navigating evolving regulations, variable infrastructure, and key factors influencing diagnostic value creation.

Conclusion

Strategic choices in hepatitis test solutions rely on the alignment of innovation, operational resilience, and regulatory compliance. This analysis provides evidence-based insights to enable confident investment decisions and improved diagnostic outcomes.

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Definition
1.3. Market Segmentation & Coverage
1.4. Years Considered for the Study
1.5. Currency Considered for the Study
1.6. Language Considered for the Study
1.7. Key Stakeholders
2. Research Methodology
2.1. Introduction
2.2. Research Design
2.2.1. Primary Research
2.2.2. Secondary Research
2.3. Research Framework
2.3.1. Qualitative Analysis
2.3.2. Quantitative Analysis
2.4. Market Size Estimation
2.4.1. Top-Down Approach
2.4.2. Bottom-Up Approach
2.5. Data Triangulation
2.6. Research Outcomes
2.7. Research Assumptions
2.8. Research Limitations
3. Executive Summary
3.1. Introduction
3.2. CXO Perspective
3.3. Market Size & Growth Trends
3.4. Market Share Analysis, 2025
3.5. FPNV Positioning Matrix, 2025
3.6. New Revenue Opportunities
3.7. Next-Generation Business Models
3.8. Industry Roadmap
4. Market Overview
4.1. Introduction
4.2. Industry Ecosystem & Value Chain Analysis
4.2.1. Supply-Side Analysis
4.2.2. Demand-Side Analysis
4.2.3. Stakeholder Analysis
4.3. Porter’s Five Forces Analysis
4.4. PESTLE Analysis
4.5. Market Outlook
4.5.1. Near-Term Market Outlook (0-2 Years)
4.5.2. Medium-Term Market Outlook (3-5 Years)
4.5.3. Long-Term Market Outlook (5-10 Years)
4.6. Go-to-Market Strategy
5. Market Insights
5.1. Consumer Insights & End-User Perspective
5.2. Consumer Experience Benchmarking
5.3. Opportunity Mapping
5.4. Distribution Channel Analysis
5.5. Pricing Trend Analysis
5.6. Regulatory Compliance & Standards Framework
5.7. ESG & Sustainability Analysis
5.8. Disruption & Risk Scenarios
5.9. Return on Investment & Cost-Benefit Analysis
6. Cumulative Impact of United States Tariffs 2025
7. Cumulative Impact of Artificial Intelligence 2025
8. Hepatitis Test Solution/Diagnosis Market, by Product Type
8.1. Instruments
8.1.1. Bench-Top Instruments
8.1.2. High-Throughput Instruments
8.2. Kits & Reagents
8.2.1. Chromatography Kits
8.2.2. Immunoassay Kits
8.2.3. Molecular Assay Kits
8.3. Software & Services
9. Hepatitis Test Solution/Diagnosis Market, by Technology
9.1. Chromatography
9.1.1. Fia
9.1.2. Hplc
9.2. Immunoassay
9.2.1. Chemiluminescent Immunoassays
9.2.2. Elisa
9.2.3. Rapid Immunoassays
9.3. Molecular Diagnostics
9.3.1. Isothermal Amplification
9.3.2. Pcr
9.3.3. Real-Time Pcr
10. Hepatitis Test Solution/Diagnosis Market, by Test Type
10.1. Confirmatory Tests
10.1.1. Elisa Confirmatory
10.1.2. Pcr Confirmatory
10.2. Screening Tests
11. Hepatitis Test Solution/Diagnosis Market, by Application
11.1. Clinical Diagnostics
11.2. Research
12. Hepatitis Test Solution/Diagnosis Market, by End User
12.1. Blood Banks
12.2. Clinics
12.3. Diagnostic Laboratories
12.3.1. Hospital-Based Laboratories
12.3.2. Independent Laboratories
12.4. Home Care Settings
12.5. Hospitals
12.5.1. General Hospitals
12.5.2. Specialized Hospitals
13. Hepatitis Test Solution/Diagnosis Market, by Region
13.1. Americas
13.1.1. North America
13.1.2. Latin America
13.2. Europe, Middle East & Africa
13.2.1. Europe
13.2.2. Middle East
13.2.3. Africa
13.3. Asia-Pacific
14. Hepatitis Test Solution/Diagnosis Market, by Group
14.1. ASEAN
14.2. GCC
14.3. European Union
14.4. BRICS
14.5. G7
14.6. NATO
15. Hepatitis Test Solution/Diagnosis Market, by Country
15.1. United States
15.2. Canada
15.3. Mexico
15.4. Brazil
15.5. United Kingdom
15.6. Germany
15.7. France
15.8. Russia
15.9. Italy
15.10. Spain
15.11. China
15.12. India
15.13. Japan
15.14. Australia
15.15. South Korea
16. United States Hepatitis Test Solution/Diagnosis Market
17. China Hepatitis Test Solution/Diagnosis Market
18. Competitive Landscape
18.1. Market Concentration Analysis, 2025
18.1.1. Concentration Ratio (CR)
18.1.2. Herfindahl Hirschman Index (HHI)
18.2. Recent Developments & Impact Analysis, 2025
18.3. Product Portfolio Analysis, 2025
18.4. Benchmarking Analysis, 2025
18.5. Abbott Laboratories
18.6. AbbVie Inc.
18.7. Avantor Inc.
18.8. Beckman Coulter, Inc.
18.9. Bio-Rad Laboratories Inc.
18.10. bioMérieux SA
18.11. Cepheid
18.12. Creative Diagnostics
18.13. DiaSorin S.p.A.
18.14. Epitope Diagnostics, Inc.
18.15. Everlywell, Inc.
18.16. F. Hoffmann-La Roche AG
18.17. FUJIREBIO Inc.
18.18. GenMark Diagnostics, Inc.
18.19. Grifols S.A.
18.20. Hologic, Inc.
18.21. Laboratory Corporation of America Holdings
18.22. MedMira Inc.
18.23. Merck & Co., Inc
18.24. Meridian Bioscience, Inc.
List of Figures
FIGURE 1. GLOBAL HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 2. GLOBAL HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SHARE, BY KEY PLAYER, 2025
FIGURE 3. GLOBAL HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET, FPNV POSITIONING MATRIX, 2025
FIGURE 4. GLOBAL HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY PRODUCT TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 5. GLOBAL HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY TECHNOLOGY, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 6. GLOBAL HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY TEST TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 7. GLOBAL HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY APPLICATION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 8. GLOBAL HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 9. GLOBAL HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 10. GLOBAL HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 11. GLOBAL HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 12. UNITED STATES HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 13. CHINA HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, 2018-2032 (USD MILLION)
List of Tables
TABLE 1. GLOBAL HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 2. GLOBAL HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 3. GLOBAL HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY INSTRUMENTS, BY REGION, 2018-2032 (USD MILLION)
TABLE 4. GLOBAL HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY INSTRUMENTS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 5. GLOBAL HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY INSTRUMENTS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 6. GLOBAL HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY INSTRUMENTS, 2018-2032 (USD MILLION)
TABLE 7. GLOBAL HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY BENCH-TOP INSTRUMENTS, BY REGION, 2018-2032 (USD MILLION)
TABLE 8. GLOBAL HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY BENCH-TOP INSTRUMENTS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 9. GLOBAL HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY BENCH-TOP INSTRUMENTS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 10. GLOBAL HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY HIGH-THROUGHPUT INSTRUMENTS, BY REGION, 2018-2032 (USD MILLION)
TABLE 11. GLOBAL HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY HIGH-THROUGHPUT INSTRUMENTS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 12. GLOBAL HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY HIGH-THROUGHPUT INSTRUMENTS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 13. GLOBAL HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY KITS & REAGENTS, BY REGION, 2018-2032 (USD MILLION)
TABLE 14. GLOBAL HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY KITS & REAGENTS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 15. GLOBAL HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY KITS & REAGENTS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 16. GLOBAL HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY KITS & REAGENTS, 2018-2032 (USD MILLION)
TABLE 17. GLOBAL HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY CHROMATOGRAPHY KITS, BY REGION, 2018-2032 (USD MILLION)
TABLE 18. GLOBAL HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY CHROMATOGRAPHY KITS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 19. GLOBAL HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY CHROMATOGRAPHY KITS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 20. GLOBAL HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY IMMUNOASSAY KITS, BY REGION, 2018-2032 (USD MILLION)
TABLE 21. GLOBAL HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY IMMUNOASSAY KITS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 22. GLOBAL HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY IMMUNOASSAY KITS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 23. GLOBAL HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY MOLECULAR ASSAY KITS, BY REGION, 2018-2032 (USD MILLION)
TABLE 24. GLOBAL HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY MOLECULAR ASSAY KITS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 25. GLOBAL HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY MOLECULAR ASSAY KITS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 26. GLOBAL HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY SOFTWARE & SERVICES, BY REGION, 2018-2032 (USD MILLION)
TABLE 27. GLOBAL HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY SOFTWARE & SERVICES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 28. GLOBAL HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY SOFTWARE & SERVICES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 29. GLOBAL HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 30. GLOBAL HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY CHROMATOGRAPHY, BY REGION, 2018-2032 (USD MILLION)
TABLE 31. GLOBAL HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY CHROMATOGRAPHY, BY GROUP, 2018-2032 (USD MILLION)
TABLE 32. GLOBAL HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY CHROMATOGRAPHY, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 33. GLOBAL HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY CHROMATOGRAPHY, 2018-2032 (USD MILLION)
TABLE 34. GLOBAL HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY FIA, BY REGION, 2018-2032 (USD MILLION)
TABLE 35. GLOBAL HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY FIA, BY GROUP, 2018-2032 (USD MILLION)
TABLE 36. GLOBAL HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY FIA, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 37. GLOBAL HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY HPLC, BY REGION, 2018-2032 (USD MILLION)
TABLE 38. GLOBAL HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY HPLC, BY GROUP, 2018-2032 (USD MILLION)
TABLE 39. GLOBAL HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY HPLC, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 40. GLOBAL HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY IMMUNOASSAY, BY REGION, 2018-2032 (USD MILLION)
TABLE 41. GLOBAL HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY IMMUNOASSAY, BY GROUP, 2018-2032 (USD MILLION)
TABLE 42. GLOBAL HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY IMMUNOASSAY, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 43. GLOBAL HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY IMMUNOASSAY, 2018-2032 (USD MILLION)
TABLE 44. GLOBAL HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY CHEMILUMINESCENT IMMUNOASSAYS, BY REGION, 2018-2032 (USD MILLION)
TABLE 45. GLOBAL HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY CHEMILUMINESCENT IMMUNOASSAYS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 46. GLOBAL HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY CHEMILUMINESCENT IMMUNOASSAYS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 47. GLOBAL HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY ELISA, BY REGION, 2018-2032 (USD MILLION)
TABLE 48. GLOBAL HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY ELISA, BY GROUP, 2018-2032 (USD MILLION)
TABLE 49. GLOBAL HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY ELISA, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 50. GLOBAL HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY RAPID IMMUNOASSAYS, BY REGION, 2018-2032 (USD MILLION)
TABLE 51. GLOBAL HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY RAPID IMMUNOASSAYS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 52. GLOBAL HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY RAPID IMMUNOASSAYS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 53. GLOBAL HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY MOLECULAR DIAGNOSTICS, BY REGION, 2018-2032 (USD MILLION)
TABLE 54. GLOBAL HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY MOLECULAR DIAGNOSTICS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 55. GLOBAL HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY MOLECULAR DIAGNOSTICS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 56. GLOBAL HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2018-2032 (USD MILLION)
TABLE 57. GLOBAL HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY ISOTHERMAL AMPLIFICATION, BY REGION, 2018-2032 (USD MILLION)
TABLE 58. GLOBAL HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY ISOTHERMAL AMPLIFICATION, BY GROUP, 2018-2032 (USD MILLION)
TABLE 59. GLOBAL HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY ISOTHERMAL AMPLIFICATION, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 60. GLOBAL HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY PCR, BY REGION, 2018-2032 (USD MILLION)
TABLE 61. GLOBAL HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY PCR, BY GROUP, 2018-2032 (USD MILLION)
TABLE 62. GLOBAL HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY PCR, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 63. GLOBAL HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY REAL-TIME PCR, BY REGION, 2018-2032 (USD MILLION)
TABLE 64. GLOBAL HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY REAL-TIME PCR, BY GROUP, 2018-2032 (USD MILLION)
TABLE 65. GLOBAL HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY REAL-TIME PCR, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 66. GLOBAL HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY TEST TYPE, 2018-2032 (USD MILLION)
TABLE 67. GLOBAL HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY CONFIRMATORY TESTS, BY REGION, 2018-2032 (USD MILLION)
TABLE 68. GLOBAL HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY CONFIRMATORY TESTS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 69. GLOBAL HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY CONFIRMATORY TESTS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 70. GLOBAL HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY CONFIRMATORY TESTS, 2018-2032 (USD MILLION)
TABLE 71. GLOBAL HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY ELISA CONFIRMATORY, BY REGION, 2018-2032 (USD MILLION)
TABLE 72. GLOBAL HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY ELISA CONFIRMATORY, BY GROUP, 2018-2032 (USD MILLION)
TABLE 73. GLOBAL HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY ELISA CONFIRMATORY, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 74. GLOBAL HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY PCR CONFIRMATORY, BY REGION, 2018-2032 (USD MILLION)
TABLE 75. GLOBAL HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY PCR CONFIRMATORY, BY GROUP, 2018-2032 (USD MILLION)
TABLE 76. GLOBAL HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY PCR CONFIRMATORY, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 77. GLOBAL HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY SCREENING TESTS, BY REGION, 2018-2032 (USD MILLION)
TABLE 78. GLOBAL HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY SCREENING TESTS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 79. GLOBAL HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY SCREENING TESTS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 80. GLOBAL HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 81. GLOBAL HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY CLINICAL DIAGNOSTICS, BY REGION, 2018-2032 (USD MILLION)
TABLE 82. GLOBAL HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY CLINICAL DIAGNOSTICS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 83. GLOBAL HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY CLINICAL DIAGNOSTICS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 84. GLOBAL HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY RESEARCH, BY REGION, 2018-2032 (USD MILLION)
TABLE 85. GLOBAL HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY RESEARCH, BY GROUP, 2018-2032 (USD MILLION)
TABLE 86. GLOBAL HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY RESEARCH, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 87. GLOBAL HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 88. GLOBAL HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY BLOOD BANKS, BY REGION, 2018-2032 (USD MILLION)
TABLE 89. GLOBAL HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY BLOOD BANKS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 90. GLOBAL HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY BLOOD BANKS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 91. GLOBAL HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY CLINICS, BY REGION, 2018-2032 (USD MILLION)
TABLE 92. GLOBAL HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY CLINICS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 93. GLOBAL HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY CLINICS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 94. GLOBAL HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY DIAGNOSTIC LABORATORIES, BY REGION, 2018-2032 (USD MILLION)
TABLE 95. GLOBAL HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY DIAGNOSTIC LABORATORIES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 96. GLOBAL HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY DIAGNOSTIC LABORATORIES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 97. GLOBAL HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY DIAGNOSTIC LABORATORIES, 2018-2032 (USD MILLION)
TABLE 98. GLOBAL HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY HOSPITAL-BASED LABORATORIES, BY REGION, 2018-2032 (USD MILLION)
TABLE 99. GLOBAL HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY HOSPITAL-BASED LABORATORIES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 100. GLOBAL HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY HOSPITAL-BASED LABORATORIES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 101. GLOBAL HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY INDEPENDENT LABORATORIES, BY REGION, 2018-2032 (USD MILLION)
TABLE 102. GLOBAL HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY INDEPENDENT LABORATORIES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 103. GLOBAL HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY INDEPENDENT LABORATORIES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 104. GLOBAL HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY HOME CARE SETTINGS, BY REGION, 2018-2032 (USD MILLION)
TABLE 105. GLOBAL HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY HOME CARE SETTINGS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 106. GLOBAL HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY HOME CARE SETTINGS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 107. GLOBAL HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2032 (USD MILLION)
TABLE 108. GLOBAL HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY HOSPITALS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 109. GLOBAL HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 110. GLOBAL HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
TABLE 111. GLOBAL HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY GENERAL HOSPITALS, BY REGION, 2018-2032 (USD MILLION)
TABLE 112. GLOBAL HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY GENERAL HOSPITALS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 113. GLOBAL HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY GENERAL HOSPITALS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 114. GLOBAL HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY SPECIALIZED HOSPITALS, BY REGION, 2018-2032 (USD MILLION)
TABLE 115. GLOBAL HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY SPECIALIZED HOSPITALS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 116. GLOBAL HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY SPECIALIZED HOSPITALS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 117. GLOBAL HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 118. AMERICAS HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
TABLE 119. AMERICAS HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 120. AMERICAS HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY INSTRUMENTS, 2018-2032 (USD MILLION)
TABLE 121. AMERICAS HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY KITS & REAGENTS, 2018-2032 (USD MILLION)
TABLE 122. AMERICAS HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 123. AMERICAS HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY CHROMATOGRAPHY, 2018-2032 (USD MILLION)
TABLE 124. AMERICAS HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY IMMUNOASSAY, 2018-2032 (USD MILLION)
TABLE 125. AMERICAS HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2018-2032 (USD MILLION)
TABLE 126. AMERICAS HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY TEST TYPE, 2018-2032 (USD MILLION)
TABLE 127. AMERICAS HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY CONFIRMATORY TESTS, 2018-2032 (USD MILLION)
TABLE 128. AMERICAS HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 129. AMERICAS HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 130. AMERICAS HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY DIAGNOSTIC LABORATORIES, 2018-2032 (USD MILLION)
TABLE 131. AMERICAS HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
TABLE 132. NORTH AMERICA HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 133. NORTH AMERICA HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 134. NORTH AMERICA HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY INSTRUMENTS, 2018-2032 (USD MILLION)
TABLE 135. NORTH AMERICA HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY KITS & REAGENTS, 2018-2032 (USD MILLION)
TABLE 136. NORTH AMERICA HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 137. NORTH AMERICA HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY CHROMATOGRAPHY, 2018-2032 (USD MILLION)
TABLE 138. NORTH AMERICA HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY IMMUNOASSAY, 2018-2032 (USD MILLION)
TABLE 139. NORTH AMERICA HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2018-2032 (USD MILLION)
TABLE 140. NORTH AMERICA HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY TEST TYPE, 2018-2032 (USD MILLION)
TABLE 141. NORTH AMERICA HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY CONFIRMATORY TESTS, 2018-2032 (USD MILLION)
TABLE 142. NORTH AMERICA HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 143. NORTH AMERICA HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 144. NORTH AMERICA HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY DIAGNOSTIC LABORATORIES, 2018-2032 (USD MILLION)
TABLE 145. NORTH AMERICA HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
TABLE 146. LATIN AMERICA HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 147. LATIN AMERICA HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 148. LATIN AMERICA HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY INSTRUMENTS, 2018-2032 (USD MILLION)
TABLE 149. LATIN AMERICA HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY KITS & REAGENTS, 2018-2032 (USD MILLION)
TABLE 150. LATIN AMERICA HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 151. LATIN AMERICA HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY CHROMATOGRAPHY, 2018-2032 (USD MILLION)
TABLE 152. LATIN AMERICA HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY IMMUNOASSAY, 2018-2032 (USD MILLION)
TABLE 153. LATIN AMERICA HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2018-2032 (USD MILLION)
TABLE 154. LATIN AMERICA HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY TEST TYPE, 2018-2032 (USD MILLION)
TABLE 155. LATIN AMERICA HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY CONFIRMATORY TESTS, 2018-2032 (USD MILLION)
TABLE 156. LATIN AMERICA HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 157. LATIN AMERICA HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 158. LATIN AMERICA HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY DIAGNOSTIC LABORATORIES, 2018-2032 (USD MILLION)
TABLE 159. LATIN AMERICA HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
TABLE 160. EUROPE, MIDDLE EAST & AFRICA HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
TABLE 161. EUROPE, MIDDLE EAST & AFRICA HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 162. EUROPE, MIDDLE EAST & AFRICA HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY INSTRUMENTS, 2018-2032 (USD MILLION)
TABLE 163. EUROPE, MIDDLE EAST & AFRICA HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY KITS & REAGENTS, 2018-2032 (USD MILLION)
TABLE 164. EUROPE, MIDDLE EAST & AFRICA HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 165. EUROPE, MIDDLE EAST & AFRICA HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY CHROMATOGRAPHY, 2018-2032 (USD MILLION)
TABLE 166. EUROPE, MIDDLE EAST & AFRICA HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY IMMUNOASSAY, 2018-2032 (USD MILLION)
TABLE 167. EUROPE, MIDDLE EAST & AFRICA HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2018-2032 (USD MILLION)
TABLE 168. EUROPE, MIDDLE EAST & AFRICA HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY TEST TYPE, 2018-2032 (USD MILLION)
TABLE 169. EUROPE, MIDDLE EAST & AFRICA HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY CONFIRMATORY TESTS, 2018-2032 (USD MILLION)
TABLE 170. EUROPE, MIDDLE EAST & AFRICA HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 171. EUROPE, MIDDLE EAST & AFRICA HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 172. EUROPE, MIDDLE EAST & AFRICA HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY DIAGNOSTIC LABORATORIES, 2018-2032 (USD MILLION)
TABLE 173. EUROPE, MIDDLE EAST & AFRICA HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
TABLE 174. EUROPE HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 175. EUROPE HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 176. EUROPE HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY INSTRUMENTS, 2018-2032 (USD MILLION)
TABLE 177. EUROPE HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY KITS & REAGENTS, 2018-2032 (USD MILLION)
TABLE 178. EUROPE HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 179. EUROPE HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY CHROMATOGRAPHY, 2018-2032 (USD MILLION)
TABLE 180. EUROPE HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY IMMUNOASSAY, 2018-2032 (USD MILLION)
TABLE 181. EUROPE HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2018-2032 (USD MILLION)
TABLE 182. EUROPE HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY TEST TYPE, 2018-2032 (USD MILLION)
TABLE 183. EUROPE HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY CONFIRMATORY TESTS, 2018-2032 (USD MILLION)
TABLE 184. EUROPE HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 185. EUROPE HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 186. EUROPE HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY DIAGNOSTIC LABORATORIES, 2018-2032 (USD MILLION)
TABLE 187. EUROPE HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
TABLE 188. MIDDLE EAST HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 189. MIDDLE EAST HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 190. MIDDLE EAST HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY INSTRUMENTS, 2018-2032 (USD MILLION)
TABLE 191. MIDDLE EAST HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY KITS & REAGENTS, 2018-2032 (USD MILLION)
TABLE 192. MIDDLE EAST HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 193. MIDDLE EAST HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY CHROMATOGRAPHY, 2018-2032 (USD MILLION)
TABLE 194. MIDDLE EAST HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY IMMUNOASSAY, 2018-2032 (USD MILLION)
TABLE 195. MIDDLE EAST HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2018-2032 (USD MILLION)
TABLE 196. MIDDLE EAST HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY TEST TYPE, 2018-2032 (USD MILLION)
TABLE 197. MIDDLE EAST HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY CONFIRMATORY TESTS, 2018-2032 (USD MILLION)
TABLE 198. MIDDLE EAST HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 199. MIDDLE EAST HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 200. MIDDLE EAST HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY DIAGNOSTIC LABORATORIES, 2018-2032 (USD MILLION)
TABLE 201. MIDDLE EAST HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
TABLE 202. AFRICA HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 203. AFRICA HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 204. AFRICA HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY INSTRUMENTS, 2018-2032 (USD MILLION)
TABLE 205. AFRICA HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY KITS & REAGENTS, 2018-2032 (USD MILLION)
TABLE 206. AFRICA HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 207. AFRICA HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY CHROMATOGRAPHY, 2018-2032 (USD MILLION)
TABLE 208. AFRICA HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY IMMUNOASSAY, 2018-2032 (USD MILLION)
TABLE 209. AFRICA HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2018-2032 (USD MILLION)
TABLE 210. AFRICA HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY TEST TYPE, 2018-2032 (USD MILLION)
TABLE 211. AFRICA HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY CONFIRMATORY TESTS, 2018-2032 (USD MILLION)
TABLE 212. AFRICA HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 213. AFRICA HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 214. AFRICA HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY DIAGNOSTIC LABORATORIES, 2018-2032 (USD MILLION)
TABLE 215. AFRICA HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
TABLE 216. ASIA-PACIFIC HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 217. ASIA-PACIFIC HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 218. ASIA-PACIFIC HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY INSTRUMENTS, 2018-2032 (USD MILLION)
TABLE 219. ASIA-PACIFIC HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY KITS & REAGENTS, 2018-2032 (USD MILLION)
TABLE 220. ASIA-PACIFIC HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 221. ASIA-PACIFIC HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY CHROMATOGRAPHY, 2018-2032 (USD MILLION)
TABLE 222. ASIA-PACIFIC HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY IMMUNOASSAY, 2018-2032 (USD MILLION)
TABLE 223. ASIA-PACIFIC HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2018-2032 (USD MILLION)
TABLE 224. ASIA-PACIFIC HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY TEST TYPE, 2018-2032 (USD MILLION)
TABLE 225. ASIA-PACIFIC HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY CONFIRMATORY TESTS, 2018-2032 (USD MILLION)
TABLE 226. ASIA-PACIFIC HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 227. ASIA-PACIFIC HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 228. ASIA-PACIFIC HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY DIAGNOSTIC LABORATORIES, 2018-2032 (USD MILLION)
TABLE 229. ASIA-PACIFIC HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
TABLE 230. GLOBAL HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 231. ASEAN HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 232. ASEAN HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 233. ASEAN HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY INSTRUMENTS, 2018-2032 (USD MILLION)
TABLE 234. ASEAN HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY KITS & REAGENTS, 2018-2032 (USD MILLION)
TABLE 235. ASEAN HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 236. ASEAN HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY CHROMATOGRAPHY, 2018-2032 (USD MILLION)
TABLE 237. ASEAN HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY IMMUNOASSAY, 2018-2032 (USD MILLION)
TABLE 238. ASEAN HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2018-2032 (USD MILLION)
TABLE 239. ASEAN HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY TEST TYPE, 2018-2032 (USD MILLION)
TABLE 240. ASEAN HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY CONFIRMATORY TESTS, 2018-2032 (USD MILLION)
TABLE 241. ASEAN HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 242. ASEAN HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 243. ASEAN HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY DIAGNOSTIC LABORATORIES, 2018-2032 (USD MILLION)
TABLE 244. ASEAN HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
TABLE 245. GCC HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 246. GCC HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 247. GCC HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY INSTRUMENTS, 2018-2032 (USD MILLION)
TABLE 248. GCC HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY KITS & REAGENTS, 2018-2032 (USD MILLION)
TABLE 249. GCC HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 250. GCC HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY CHROMATOGRAPHY, 2018-2032 (USD MILLION)
TABLE 251. GCC HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY IMMUNOASSAY, 2018-2032 (USD MILLION)
TABLE 252. GCC HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2018-2032 (USD MILLION)
TABLE 253. GCC HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY TEST TYPE, 2018-2032 (USD MILLION)
TABLE 254. GCC HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY CONFIRMATORY TESTS, 2018-2032 (USD MILLION)
TABLE 255. GCC HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 256. GCC HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 257. GCC HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY DIAGNOSTIC LABORATORIES, 2018-2032 (USD MILLION)
TABLE 258. GCC HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
TABLE 259. EUROPEAN UNION HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 260. EUROPEAN UNION HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 261. EUROPEAN UNION HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY INSTRUMENTS, 2018-2032 (USD MILLION)
TABLE 262. EUROPEAN UNION HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY KITS & REAGENTS, 2018-2032 (USD MILLION)
TABLE 263. EUROPEAN UNION HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 264. EUROPEAN UNION HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY CHROMATOGRAPHY, 2018-2032 (USD MILLION)
TABLE 265. EUROPEAN UNION HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY IMMUNOASSAY, 2018-2032 (USD MILLION)
TABLE 266. EUROPEAN UNION HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2018-2032 (USD MILLION)
TABLE 267. EUROPEAN UNION HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY TEST TYPE, 2018-2032 (USD MILLION)
TABLE 268. EUROPEAN UNION HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY CONFIRMATORY TESTS, 2018-2032 (USD MILLION)
TABLE 269. EUROPEAN UNION HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 270. EUROPEAN UNION HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 271. EUROPEAN UNION HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY DIAGNOSTIC LABORATORIES, 2018-2032 (USD MILLION)
TABLE 272. EUROPEAN UNION HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
TABLE 273. BRICS HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 274. BRICS HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 275. BRICS HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY INSTRUMENTS, 2018-2032 (USD MILLION)
TABLE 276. BRICS HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY KITS & REAGENTS, 2018-2032 (USD MILLION)
TABLE 277. BRICS HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 278. BRICS HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY CHROMATOGRAPHY, 2018-2032 (USD MILLION)
TABLE 279. BRICS HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY IMMUNOASSAY, 2018-2032 (USD MILLION)
TABLE 280. BRICS HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2018-2032 (USD MILLION)
TABLE 281. BRICS HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY TEST TYPE, 2018-2032 (USD MILLION)
TABLE 282. BRICS HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY CONFIRMATORY TESTS, 2018-2032 (USD MILLION)
TABLE 283. BRICS HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 284. BRICS HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 285. BRICS HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY DIAGNOSTIC LABORATORIES, 2018-2032 (USD MILLION)
TABLE 286. BRICS HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
TABLE 287. G7 HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 288. G7 HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY PRODUCT TYPE,

Companies Mentioned

The key companies profiled in this Hepatitis Test Solution/Diagnosis market report include:
  • Abbott Laboratories
  • AbbVie Inc.
  • Avantor Inc.
  • Beckman Coulter, Inc.
  • Bio-Rad Laboratories Inc.
  • bioMérieux SA
  • Cepheid
  • Creative Diagnostics
  • DiaSorin S.p.A.
  • Epitope Diagnostics, Inc.
  • Everlywell, Inc.
  • F. Hoffmann-La Roche AG
  • FUJIREBIO Inc.
  • GenMark Diagnostics, Inc.
  • Grifols S.A.
  • Hologic, Inc.
  • Laboratory Corporation of America Holdings
  • MedMira Inc.
  • Merck & Co., Inc
  • Meridian Bioscience, Inc.

Table Information

Report AttributeDetails
No. of Pages195
PublishedJanuary 2026
Forecast Period2026 - 2032
Estimated Market Value ( USD ) in 2026 $ 4.14 Billion
Forecasted Market Value ( USD ) by 2032 $ 5.79 Billion
Compound Annual Growth Rate5.7%
Regions CoveredGlobal
No. of Companies Mentioned21

Related Topics

Related Reports

Viral Hepatitis Test Kit Market - Global Forecast 2025-2030 - Product Image

Viral Hepatitis Test Kit Market - Global Forecast 2025-2030

  • Report
  • 196 Pages
  • Global
From
Hepatitis B and C Diagnostics Market - Global Strategic Business Report - Product Image

Hepatitis B and C Diagnostics Market - Global Strategic Business Report

  • Report
  • 275 Pages
  • Global
From
Hepatitis Test Solution/Diagnosis - Global Strategic Business Report - Product Image

Hepatitis Test Solution/Diagnosis - Global Strategic Business Report

  • Report
  • 275 Pages
  • Global
From
Global Hepatitis Diagnostic Test - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts (2025 - 2030) - Product Image

Global Hepatitis Diagnostic Test - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts (2025 - 2030)

  • Report
  • 110 Pages
  • Global
From
Hepatitis Diagnostic Tests Market Report 2025 - Product Image

Hepatitis Diagnostic Tests Market Report 2025

  • Report
  • 200 Pages
  • Global
From

About the Market

In the realm of infectious disease testing, the hepatitis test solution diagnosis market comprises a segment focused on detecting and quantifying the presence of hepatitis infections, which include Hepatitis A, B, C, D, and E. Diagnosis of these conditions is critical due to their impact on liver function and potential for causing liver disease, cirrhosis, or carcinoma. The market includes a variety of testing modalities such as immunoassay-based tests, PCR-based tests, and point-of-care testing platforms. These diagnostic tools help in screening blood donations, monitoring the disease, and managing treatment regimens for infected patients. Advances in biotechnology have led to the development of more rapid and sensitive tests, facilitating early detection and improved patient outcomes. Numerous enterprises partake in the hepatitis test solution diagnosis market. Some notable companies include Abbott Laboratories, known for their range of immunoassays and laboratory equipment; Roche Diagnostics, offering advanced molecular assays; Siemens Healthineers, providing a comprehensive suite of diagnostic solutions; and QIAGEN, which supplies technologies for nucleic acid amplification testing. Additionally, Bio-Rad Laboratories and Beckman Coulter offer a variety of testing reagents and instruments that support hepatitis diagnosis. Show Less Read more

Copyright © 2002-2026 Research and Markets. All Rights Reserved.